Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia
Phase 3
Not yet recruiting
- Conditions
- Angina, Stable
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Angionetics Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT02928094
News
No news found